NCT06897982 Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center
| NCT ID | NCT06897982 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cedars-Sinai Medical Center |
| Condition | Prediabetic State |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-12-08 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-12-08 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to assess the feasibility and acceptability of incorporating hands-on nutritional demonstrations to enhance the Diabetes Prevention Program (DPP) curriculum among patients who are at-risk for prediabetes
Eligibility Criteria
Inclusion Criteria: * 18+ years old * BMI of 25 or higher (23 or higher if Asian) * Meet specific blood sugar test criteria indicating prediabetes, such as a fasting plasma glucose level between 110-125 mg/dL or an A1C level between 5.7-6.4% * Not be diagnosed with type 1 or type 2 diabetes * Moderate to high risk of having prediabetes or a known diagnosis of prediabetes by their medical provider in the last 12 months. * Eligible or enrolled in the Diabetes Prevention Program Exclusion Criteria: * Younger than 18 years of age * BMI of less than 25 or higher (or under 23 if Asian) * Does not meet specific blood sugar test criteria indicating prediabetes, such as a fasting plasma glucose level between 110-125 mg/dL or an A1C level between 5.7-6.4% * Currently diagnosed with type 1 or type 2 diabetes * Has not been diagnosed as moderate to high risk of having prediabetes or having a known diagnosis of prediabetes by their medical provider in the last 12 months.
Contact & Investigator
Yelba Castellon-Lopez, MD
PRINCIPAL INVESTIGATOR
Cedars-Sinai Medical Center
Frequently Asked Questions
Who can join the NCT06897982 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Prediabetic State. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06897982 currently recruiting?
Yes, NCT06897982 is actively recruiting participants. Contact the research team at leslie.aguilar-hernandez@cshs.org for enrollment information.
Where is the NCT06897982 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT06897982 clinical trial?
NCT06897982 is sponsored by Cedars-Sinai Medical Center. The principal investigator is Yelba Castellon-Lopez, MD at Cedars-Sinai Medical Center. The trial plans to enroll 20 participants.